APA (7th ed.) Citation

Jeong, A., Weisel, K., Dimitrova, D., Donnelly, B., Wang, D., Vermeulen, A., & Xu, Z. (2026). A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers. Clinical Pharmacology in Drug Development, 15(1), 1. https://doi.org/10.1002/cpdd.70007

Chicago Style (17th ed.) Citation

Jeong, Angela, Kathleen Weisel, Dessislava Dimitrova, Brianna Donnelly, Daniel Wang, An Vermeulen, and Zhenhua Xu. "A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers." Clinical Pharmacology in Drug Development 15, no. 1 (2026): 1. https://doi.org/10.1002/cpdd.70007.

MLA (9th ed.) Citation

Jeong, Angela, et al. "A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers." Clinical Pharmacology in Drug Development, vol. 15, no. 1, 2026, p. 1, https://doi.org/10.1002/cpdd.70007.